Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

aap Implantate AG Issues Q4 2013 Sales And EBITDA Guidance


Monday, 11 Nov 2013 02:31am EST 

aap Implantate AG announced that for the fourth quarter of 2013, the management board forecasts sales in the range of EUR10.5 million to EUR11.6 million and an EBITDA of EUR1.3 million to EUR1.7 million. Sales and profitability will be mainly driven by sales of trauma products, especially LOQTEQ(R), and as previously announced, bone cement and cementing devices. 

Company Quote

2.83
0.031 +1.11%
15 Aug 2014